Clearline Capital LP - 31 Dec 2025 SCHEDULE 13G/A Report for HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share (HRTX)

Filing Manager
Clearline Capital LP
Reporting Manager
Clearline Capital LP
Security
HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share
Symbol
HRTX
Shares outstanding
182,615,507 shares
Disclosed Ownership
12,235,239 shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 14:40:59 UTC
Date of event
31 Dec 2025
Previous filing
26 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Clearline Capital LP 6.7% 12,235,239 0 12,235,239 Marc Majzner Limited Partner
Clearline Capital LLC 6.7% 12,235,239 0 12,235,239 Marc Majzner Managing Member
Marc Majzner 6.7% 12,235,239 0 12,235,239 Marc Majzner Authorized Signatory